Pune based DeepTek Medical Imaging Pvt. Ltd. collaborates with Japanese company MBM for artificial Intelligence lead solution to screen Coronavirus.

Image
ANI
Last Updated : Mar 31 2020 | 7:55 PM IST

Recently there have been notable developments in health tech diagnostics due to Artificial Intelligence tools for analyzing medical scans like X-Ray, CT and MRI. In this era where a shortage of radiologists is felt globally - Artificial Intelligence (AI) lead solutions are assisting in improving reporting quality, reduce turnaround time while helping to make medical image reading services more accessible and affordable.

DeepTek Medical Imaging Pvt. Ltd. (a Pune - India based technology venture; Managing Director - Ajit Patil) and MDM Inc. (Tokyo - Japan based medical technology venture; Representative - Chie Akusawa) announced a collaborative research and development initiative towards developing an AI based solution for screening of COVID-19 (Novel Coronavirus) using chest radiography.

DeepTek has already deployed a similar population screening solution for Tuberculosis (TB) screening. It instantaneously processes chest radiographs to identify potential TB and other infections. This solution has been used for public health screening of over 75,000 individuals in India. DeepTek's TB solution is also being leveraged in the APAC region. Over 1.2 million people die of TB annually.

WHO is working on a mission to stop the TB epidemic by year 2030; while India has setup a target of the year 2025. With the rapid spread of the new COVID-19 infection globally, MBM Inc. has taken an initiative towards developing a similar solution which can help reduce stress on healthcare professionals and enable better patient care.

The solution will process chest radiographs to screen a sub- class of the broader condition of pneumonia using deep learning algorithms. This can be helpful in screening for epidemics and pandemics like the COVID-19, SARS, H1N1 outbreaks in appropriate clinical settings. The solution is expected to be available for trials from early May 2020.

MBM (http://medical-business-machines.com) is a Japanese company conducting R & D and sales of AI systems for medical use. MBM is an IBM partner in Japan. DeepTek's medical AI solution will be installed in the MBM's and AI image diagnosis support device which it plans to sell in Japan from this year and explore global opportunities in the years to follow.

This story is provided by DeepTek Medical Imaging Pvt Ltd. ANI will not be responsible in any way for the content of this article.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 31 2020 | 7:42 PM IST

Next Story